InhibrxInc Historical Financial Ratios
| INBX Stock | USD 34.45 0.16 0.46% |
InhibrxInc is lately reporting on over 99 different financial statement accounts. To analyze all of these accounts together requires a lot of time and effort. However, using these accounts to derive some meaningful and actionable indicators such as PTB Ratio of 43.23 or Days Sales Outstanding of 166 will help investors to properly organize and evaluate InhibrxInc financial condition quickly.
InhibrxInc |
About InhibrxInc Financial Ratios Analysis
InhibrxIncFinancial ratios are relationships based on a company's financial information. They can serve as useful tools to evaluate InhibrxInc investment potential. Financial ratio analysis can also be defined as the process of presenting financial ratios, which are mathematical indicators calculated by comparing key financial information appearing on InhibrxInc financial statements. Financial ratios are useful tools that help investors analyze and compare relationships between different pieces of financial information across InhibrxInc history.
InhibrxInc Financial Ratios Chart
InhibrxInc financial ratios usually calculated using numerical values taken directly from InhibrxInc financial statements such as income statements or balance sheets. They help investors to obtain meaningful information about InhibrxInc. Most financial ratios help to conduct quantitative analysis to assess vital information about the company's valuation as well as profitability and liquidity indicators such as leverage, growth, profit margins, and different types of rates of return.
At this time, InhibrxInc's Cash Per Share is fairly stable compared to the past year. Capex To Operating Cash Flow is likely to rise to 0.04 in 2024, whereas Free Cash Flow Yield is likely to drop (0.12) in 2024. Add Fundamental
Price To Sales Ratio
Price to Sales Ratio is figured by comparing InhibrxInc stock price to its revenues. An advantage to using Price to Sales ratio is that it is based on InhibrxInc sales, a figure that is much harder to manipulate than other InhibrxInc multiples. Because sales tend to be more stable P/S ratio can be a good tool for screening cyclical companies fluctuating earnings patterns. A valuation ratio that compares a company’s stock price to its revenues, calculated by dividing the company’s market cap by its total sales or revenue over a 12-month period.Dividend Yield
Dividend Yield is InhibrxInc dividend as a percentage of InhibrxInc stock price. InhibrxInc dividend yield is a measure of InhibrxInc stock productivity, which can be interpreted as interest rate earned on an InhibrxInc investment. A financial ratio that shows how much a company pays out in dividends each year relative to its stock price, calculated as annual dividends per share divided by price per share.Ev To Sales
The Enterprise Value to Sales ratio, a valuation metric used to compare the value of a company, including debt and excluding cash, to its sales revenue.Most ratios from InhibrxInc's fundamentals are interrelated and interconnected. However, analyzing fundamentals ratios one by one will only give a small insight into InhibrxInc current financial condition. On the other hand, looking into the entire matrix of fundamentals ratios, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in InhibrxInc. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in bureau of labor statistics. For more information on how to buy InhibrxInc Stock please use our How to Invest in InhibrxInc guide.At this time, InhibrxInc's Cash Per Share is fairly stable compared to the past year. Capex To Operating Cash Flow is likely to rise to 0.04 in 2024, whereas Free Cash Flow Yield is likely to drop (0.12) in 2024.
| 2023 | 2024 (projected) | Dividend Yield | 0.001705 | 0.002089 | Price To Sales Ratio | 994.97 | 1.0K |
InhibrxInc fundamentals Correlations
Click cells to compare fundamentals
InhibrxInc Account Relationship Matchups
High Positive Relationship
High Negative Relationship
InhibrxInc fundamentals Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Price To Sales Ratio | 82.93 | 65.03 | 232.97 | 453.75 | 994.97 | 1.0K | |
| Ptb Ratio | (8.06) | 11.04 | 31.69 | 17.02 | 41.17 | 43.23 | |
| Days Sales Outstanding | 17.58 | 17.53 | 44.98 | 43.07 | 157.76 | 165.65 | |
| Book Value Per Share | (2.56) | 2.99 | 1.38 | 1.45 | 0.92 | 0.97 | |
| Free Cash Flow Yield | (0.0439) | (0.0449) | (0.0592) | (0.0489) | (0.12) | (0.11) | |
| Invested Capital | (0.45) | 0.5 | 1.38 | 3.51 | 4.8 | 5.05 | |
| Operating Cash Flow Per Share | (0.88) | (1.9) | (2.11) | (2.87) | (4.1) | (4.31) | |
| Stock Based Compensation To Revenue | 0.44 | 0.39 | 2.11 | 9.39 | 13.8 | 14.49 | |
| Capex To Depreciation | (1.56) | (1.34) | (0.72) | (0.56) | (3.86) | (3.66) | |
| Pb Ratio | (8.06) | 11.04 | 31.69 | 17.02 | 41.17 | 43.23 | |
| Ev To Sales | 86.25 | 57.9 | 224.43 | 420.78 | 957.31 | 1.0K | |
| Free Cash Flow Per Share | (0.93) | (1.95) | (2.14) | (2.89) | (4.2) | (4.41) | |
| Roic | 0.86 | (0.6) | (0.61) | (0.49) | (0.87) | (0.82) | |
| Inventory Turnover | 14.94 | (0.57) | (3.06) | (11.07) | (12.74) | (12.1) | |
| Net Income Per Share | (1.41) | (2.99) | (2.15) | (3.62) | (5.12) | (5.38) | |
| Days Of Inventory On Hand | 24.43 | (642.04) | (119.22) | (32.96) | (37.9) | (39.8) | |
| Payables Turnover | 15.38 | 5.46 | 0.29 | 0.34 | 0.11 | 0.1 | |
| Sales General And Administrative To Revenue | 0.99 | 0.53 | 1.73 | 9.7 | 16.32 | 17.14 | |
| Research And Ddevelopement To Revenue | 5.27 | 5.74 | 10.03 | 50.59 | 105.92 | 111.21 | |
| Capex To Revenue | (0.2) | (0.11) | (0.12) | (0.31) | (2.55) | (2.42) | |
| Cash Per Share | 0.32 | 5.09 | 3.45 | 6.83 | 5.9 | 6.19 | |
| Pocfratio | (23.51) | (17.36) | (20.67) | (8.57) | (9.26) | (9.73) | |
| Interest Coverage | (7.64) | (6.24) | (14.68) | (8.02) | (6.89) | (7.23) | |
| Capex To Operating Cash Flow | 0.0564 | 0.0284 | 0.0108 | 0.00595 | 0.0238 | 0.0407 | |
| Pfcf Ratio | (22.25) | (16.88) | (20.45) | (8.52) | (9.05) | (9.5) | |
| Days Payables Outstanding | 23.73 | 66.84 | 1.2K | 1.1K | 3.4K | 3.5K | |
| Income Quality | 0.74 | 0.62 | 0.63 | 0.98 | 0.79 | 0.8 | |
| Roe | 0.55 | (1.0) | (1.56) | (2.5) | (5.55) | (5.27) | |
| Ev To Operating Cash Flow | (24.45) | (15.46) | (19.91) | (7.95) | (8.91) | (9.36) | |
| Pe Ratio | (14.67) | (11.01) | (20.3) | (6.8) | (7.42) | (7.79) | |
| Return On Tangible Assets | (1.94) | (0.53) | (0.54) | (0.5) | (0.78) | (0.82) | |
| Ev To Free Cash Flow | (23.14) | (15.03) | (19.7) | (7.9) | (8.71) | (9.14) | |
| Earnings Yield | (0.0682) | (0.0908) | (0.0493) | (0.15) | (0.13) | (0.14) | |
| Net Debt To E B I T D A | (0.71) | 1.35 | 0.79 | 0.56 | 0.31 | 0.22 | |
| Current Ratio | 0.76 | 4.21 | 6.2 | 10.17 | 5.25 | 3.27 | |
| Tangible Book Value Per Share | (2.56) | 2.99 | 1.38 | 1.45 | 0.92 | 0.97 | |
| Receivables Turnover | 20.76 | 20.83 | 8.12 | 8.47 | 2.31 | 2.2 | |
| Graham Number | 9.0 | 14.19 | 8.17 | 10.86 | 10.31 | 7.3 | |
| Shareholders Equity Per Share | (2.56) | 2.99 | 1.38 | 1.45 | 0.92 | 0.97 | |
| Debt To Equity | (0.45) | 0.5 | 1.38 | 3.51 | 4.8 | 5.05 |
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards InhibrxInc in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, InhibrxInc's short interest history, or implied volatility extrapolated from InhibrxInc options trading.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in InhibrxInc. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in bureau of labor statistics. For more information on how to buy InhibrxInc Stock please use our How to Invest in InhibrxInc guide.Note that the InhibrxInc information on this page should be used as a complementary analysis to other InhibrxInc's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Technical Analysis module to check basic technical indicators and analysis based on most latest market data.
Complementary Tools for InhibrxInc Stock analysis
When running InhibrxInc's price analysis, check to measure InhibrxInc's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy InhibrxInc is operating at the current time. Most of InhibrxInc's value examination focuses on studying past and present price action to predict the probability of InhibrxInc's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move InhibrxInc's price. Additionally, you may evaluate how the addition of InhibrxInc to your portfolios can decrease your overall portfolio volatility.
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Transaction History View history of all your transactions and understand their impact on performance | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets |
Is InhibrxInc's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of InhibrxInc. If investors know InhibrxInc will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about InhibrxInc listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (5.12) | Revenue Per Share 0.038 | Quarterly Revenue Growth 4.964 | Return On Assets (0.46) | Return On Equity (4.75) |
The market value of InhibrxInc is measured differently than its book value, which is the value of InhibrxInc that is recorded on the company's balance sheet. Investors also form their own opinion of InhibrxInc's value that differs from its market value or its book value, called intrinsic value, which is InhibrxInc's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because InhibrxInc's market value can be influenced by many factors that don't directly affect InhibrxInc's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between InhibrxInc's value and its price as these two are different measures arrived at by different means. Investors typically determine if InhibrxInc is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, InhibrxInc's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.